Epithelioid Soft Tissue Tumors

Seminars in Oncology

Volumn 36, Issue 4, 2009, Pages 347-357

  Dei Tos, A Paolo ^a   Wagner, Andrew J ^b   Modena, Piergiorgio ^c   Comandone, Alessandro ^d   Leyvraz, Serge ^e  

^a Treviso General Hospital   (Italy)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d GRADENIGO HOSPITAL   (Italy)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CARBOPLATIN; CISPLATIN; CORTICOSTEROID DERIVATIVE; CYTOKERATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; INTERFERON; INTERLEUKIN 2; METHOTREXATE; PACLITAXEL; TAXANE DERIVATIVE; THIOTEPA;

ALVEOLAR SOFT PART SARCOMA; AMELANOTIC MELANOMA; ANGIOSARCOMA; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; EPITHELIOID MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; EPITHELIOID SARCOMA; EPITHELIOID SMOOTH MUSCLE TUMOR; EPITHELIOID SOFT TISSUE TUMOR; FIBROSARCOMA; HEMANGIOENDOTHELIOMA; HISTOPATHOLOGY; HUMAN; LIPOSARCOMA; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; MUSCLE TUMOR; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOID TUMOR; SCLEROSING EPITHELIOID FIBROSARCOMA; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA;

FIBROSARCOMA; HEMANGIOENDOTHELIOMA, EPITHELIOID; HEMANGIOSARCOMA; HUMANS; NERVE SHEATH NEOPLASMS; SARCOMA; SMOOTH MUSCLE TUMOR;

EID: 67949115820     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.06.005     Document Type: Article

References (70)

1. Enzinger F.M. Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer 26 (1970) 1029-1041
2. Kodet R., Smelhaus V., Newton Jr. W.A., et al. Epithelioid sarcoma in childhood: an immunohistochemical, electron microscopic, and clinicopathologic study of 11 cases under 15 years of age and review of the literature. Pediatr Pathol. 14 (1994) 433-451
3. Chase D.R., and Enzinger F.M. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol. 9 (1985) 241-263
4. Bos G.D., Pritchard D.J., Reiman H.M., et al. Epithelioid sarcoma. An analysis of fifty-one cases. J Bone Joint Surg Am. 70 (1988) 862-870
5. Chase D.R., Enzinger F.M., Weiss S.W., et al. Keratin in epithelioid sarcoma. An immunohistochemical study. Am J Surg Pathol. 8 (1984) 435-441
6. Evans H.L., and Baer S.C. Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases. Semin Diagn Pathol. 10 (1993) 286-291
7. de Visscher S.A., van Ginkel R.J., Wobbes T., et al. Epithelioid sarcoma: still an only surgically curable disease. Cancer 107 (2006) 606-612
8. Miettinen M., Fanburg-Smith J.C., Virolainen M., et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 30 (1999) 934-942
9. Arber D.A., Kandalaft P.L., Mehta P., et al. Vimentin-negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34. Am J Surg Pathol. 17 (1993) 302-307
10. Wick M.R., and Manivel J.C. Epithelioid sarcoma and isolated necrobiotic granuloma: a comparative immunocytochemical study. J Cutan Pathol. 13 (1986) 253-260
11. Mirra J.M., Kessler S., Bhuta S., et al. The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer 69 (1992) 1382-1395
12. Guillou L., Wadden C., Coindre J.M., et al. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 21 (1997) 130-146
13. Bittesini L., Dei Tos A.P., and Fletcher C.D. Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern. Histopathology 20 (1992) 167-170
14. Parham D.M., Weeks D.A., and Beckwith J.B. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol. 18 (1994) 1010-1029
15. Wick M.R., Ritter J.H., and Dehner L.P. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 12 (1995) 233-248
16. Chase D.R. Do "rhabdoid features" impart a poorer prognosis to proximal-type epithelioid sarcomas?. Adv Anat Pathol. 4 (1997) 293-299
17. Hoot A.C., Russo P., Judkins A.R., et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 28 (2004) 1485-1491
18. Modena P., Lualdi E., Facchinetti F., et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 65 (2005) 4012-4019
19. Kohashi K., Izumi T., Oda Y., et al. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum Pathol. 40 (2009) 349-355
20. Chbani L., Guillou L., Terrier P., et al. Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group. Am J Clin Pathol. 131 (2009) 222-227
21. Baratti D., Pennacchioli E., Casali P.G., et al. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 14 (2007) 3542-3551
22. Callister M.D., Ballo M.T., Pisters P.W., et al. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 51 (2001) 384-391
23. Jawad M.U., Extein J., Min E.S., and Scully S.P. Progostic factors for survival in patients with epithelioid sarcoma. Clin Orthop Relat Res. (2009) Epub ahead of print DOI 10.1007/s11999-009-0749-2
24. Wolf P.S., Flum D.R., Tanas M.R., et al. Epithelioid sarcoma: the University of Washington experience. Am J Surg. 196 (2008) 407-412
25. Christopherson W.M., Foote Jr. F.W., and Stewart F.W. Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis. Cancer 5 (1952) 100-111
26. Lieberman P.H., Brennan M.F., Kimmel M., et al. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 63 (1989) 1-13
27. Portera Jr. C.A., Ho V., Patel S.R., et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 91 (2001) 585-591
28. Ladanyi M., Lui M.Y., Antonescu C.R., et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20 (2001) 48-57
29. Argani P., Antonescu C.R., Illei P.B., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 159 (2001) 179-192
30. Argani P., Lal P., Hutchinson B., et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 27 (2003) 750-761
31. Aulmann S., Longerich T., Schirmacher P., et al. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas. Histopathology 50 (2007) 881-886
32. Tsuda M., Davis I.J., Argani P., et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 67 (2007) 919-929
33. Reichardt P., Lindner T., Pink D., et al. Chemotherapy in alveolar soft part sarcomas. What do we know?. Eur J Cancer 39 (2003) 1511-1516
34. Ogose A., Yazawa Y., Ueda T., et al. Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group. Oncology 65 (2003) 7-13
35. Gardner K., Leahy M., Alvarez-Gutierrez M., et al. Activity of the VEGFR/KIT tyrosine kinase inhibitor cediranib (AZD2171) in alveolar soft part sarcoma. [abstract]. Proc Connective Tissue Oncol Soc. 14 (2008) 34936
36. Antonescu C.R., Rosenblum M.K., Pereira P., et al. Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol. 25 (2001) 699-709
37. Meis-Kindblom J.M., Kindblom L.G., and Enzinger F.M. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 19 (1995) 979-993
38. Guillou L., Benhattar J., Gengler C., et al. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol. 31 (2007) 1387-1402
39. Ossendorf C., Studer G.M., Bode B., et al. Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review. Clin Orthop Relat Res. 466 (2008) 1485-1491
40. Rosai J. Angiolymphoid hyperplasia with eosinophilia of the skin. Its nosological position in the spectrum of histiocytoid hemangioma. Am J Dermatopathol. 4 (1982) 175-184
41. Rosai J., Gold J., and Landy R. The histiocytoid hemangiomas. A unifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart. Hum Pathol. 10 (1979) 707-730
42. Weiss S.W., and Enzinger F.M. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 50 (1982) 970-981
43. Fletcher C.D., Beham A., Bekir S., et al. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol. 15 (1991) 915-924
44. Mentzel T., Beham A., Calonje E., et al. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol. 21 (1997) 363-374
45. Weitz J., Klimstra D.S., Cymes K., et al. Management of primary liver sarcomas. Cancer 109 (2007) 1391-1396
46. Rossi S., Orvieto E., Furlanetto A., et al. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 17 (2004) 547-552
47. Billings S.D., Folpe A.L., and Weiss S.W. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol. 27 (2003) 48-57
48. Mosoia L., Mabrut J.Y., Adham M., et al. Hepatic epithelioid hemangioendothelioma: long-term results of surgical management. J Surg Oncol. 98 (2008) 432-437
49. Nudo C.G., Yoshida E.M., Bain V.G., et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol. 22 (2008) 821-824
50. Bagan P., Hassan M., Le Pimpec Barthes F., et al. Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature. Ann Thorac Surg. 82 (2006) 2010-2013
51. Meis-Kindblom J.M., and Kindblom L.G. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 22 (1998) 683-697
52. Eusebi V., Carcangiu M.L., Dina R., et al. Keratin-positive epithelioid angiosarcoma of thyroid. A report of four cases. Am J Surg Pathol. 14 (1990) 737-747
53. Rosai J., Sumner H.W., Kostianovsky M., et al. Angiosarcoma of the skin. A clinicopathologic and fine structural study. Hum Pathol. 7 (1976) 83-109
54. Nagano T., Yamada Y., Ikeda T., et al. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 110 (2007) 648-651
55. Fata F., O'Reilly E., Ilson D., et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 86 (1999) 2034-2037
56. Fury M.G., Antonescu C.R., Van Zee K.J., et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 11 (2005) 241-247
57. Penel N., Bui B.N., Bay J.O., et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol. 26 (2008) 5269-5274
58. Pasquier E., Carre M., Pourroy B., et al. Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. Mol Cancer Ther. 3 (2004) 1301-1310
59. Laskin W.B., Weiss S.W., and Bratthauer G.L. Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma). Am J Surg Pathol. 15 (1991) 1136-1145
60. McMenamin M.E., and Fletcher C.D. Expanding the spectrum of malignant change in schwannomas: epithelioid malignant change, epithelioid malignant peripheral nerve sheath tumor, and epithelioid angiosarcoma: a study of 17 cases. Am J Surg Pathol. 25 (2001) 13-25
61. Prayson R.A., Goldblum J.R., and Hart W.R. Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients. Am J Surg Pathol. 21 (1999) 383-391
62. Miettinen M., and Enzinger F.M. Epithelioid variant of pleomorphic liposarcoma: a study of 12 cases of a distinctive variant of high-grade liposarcoma. Mod Pathol. 12 (1999) 722-728
63. Maki R.G., Wathen J.K., Patel S.R., et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol. 25 (2007) 2755-2763
64. Segal N.H., Pavlidis P., Antonescu C.R., et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol. 163 (2003) 691-700
65. Palmer N.F., and Sutow W. Clinical aspects of the rhabdoid tumor of the kidney: a report of the National Wilms' Tumor Study Group. Med Pediatr Oncol. 11 (1983) 242-245
66. Bonnin J.M., Rubinstein L.J., Palmer N.F., et al. The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases. Cancer 54 (1984) 2137-2146
67. Rousseau-Merck M.F., Nogues C., Roth A., et al. Hypercalcemic infantile renal tumors: morphological, clinical, and biological heterogeneity. Pediatr Pathol. 3 (1985) 155-164
68. Rousseau-Merck M.F., Versteege I., Legrand I., et al. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res. 59 (1999) 3152-3156
69. Versteege I., Sevenet N., Lange J., et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394 (1998) 203-206
70. Hornick J.L., Dal Cin P., and Fletcher C.D. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 33 (2009) 542-550